EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+2.08%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.08B
AUM Growth
+$1.08B
(-12%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-13.03%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
103
New
19
Increased
15
Reduced
30
Closed
24
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$32M |
| 2 |
Community Health Systems
CYH
|
$21.9M |
| 3 |
Organon & Co
OGN
|
$21.2M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$17.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$71.3M |
| 2 |
GSK
GSK
|
$30.3M |
| 3 |
TG Therapeutics
TGTX
|
$26.9M |
| 4 |
Elevance Health
ELV
|
$20.5M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$17.2M |
Sector Composition
| 1 | Healthcare | 90.41% |
| 2 | Industrials | 1.59% |
| 3 | Financials | 0.07% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $79.5M | 5.3% | 442,945 -43,584 | -9% | -$7.82M |
|
|
AMRN
2
Amarin Corp
AMRN
$311M
| $73M | 4.87% | 16,669,471 -227,325 | -1% | -$996K |
|
3
ARK Genomic Revolution ETF
ARKG
$1.04B
| $71.5M | 4.77% | 773,480 -33,452 | -4% | -$3.09M |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $62.4M | 4.16% | 666,738 -28,721 | -4% | -$2.69M |
|
5
AstraZeneca
AZN
$248B
| $59M | 3.94% | 985,722 -6,593 | -0.7% | -$395K |
|
|
6
Community Health Systems
CYH
$387M
| $59M | 3.93% | 3,821,729 +1,415,895 | +59% | +$21.9M |
|
7
Danaher
DHR
$147B
| $55M | 3.66% | 204,705 +27,171 | +15% | +$7.3M |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $42M | 2.8% | 335,045 +93,064 | +38% | +$11.7M |
|
9
Teva Pharmaceuticals
TEVA
$21.1B
| $37.7M | 2.51% | 3,804,405 -550,351 | -13% | -$5.45M |
|
10
Avantor
AVTR
$9.18B
| $34.6M | 2.31% | 974,637 +15,650 | +2% | +$556K |
|
|
11
Bristol-Myers Squibb
BMY
$96B
| $32M | 2.13% | +478,328 | New | +$32M |
|
12
Ascendis Pharma
ASND
$11.8B
| $31.8M | 2.12% | 241,774 -70,093 | -22% | -$9.22M |
|
13
Qiagen
QGEN
$10.1B
| $31.5M | 2.1% | 651,035 +196,314 | +43% | +$9.5M |
|
14
Fate Therapeutics
FATE
$120M
| $30.1M | 2% | 346,347 +24,587 | +8% | +$2.13M |
|
|
OCDX
15
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $29.9M | 1.99% | 1,394,284 +19,056 | +1% | +$408K |
|
16
Amneal Pharmaceuticals
AMRX
$3B
| $28.8M | 1.92% | 5,624,725 +869,245 | +18% | +$4.45M |
|
17
Envista
NVST
$3.52B
| $28.3M | 1.89% | 656,098 -76,586 | -10% | -$3.31M |
|
|
18
Organon & Co
OGN
$2.45B
| $21.2M | 1.41% | +699,696 | New | +$21.2M |
|
|
19
Ionis Pharmaceuticals
IONS
$6.79B
| $17.6M | 1.18% | +442,000 | New | +$17.6M |
|
|
RCM
20
DELISTED
R1 RCM Inc. Common Stock
RCM
| $17.1M | 1.14% | +770,000 | New | +$17.1M |
|
21
HealthEquity
HQY
$7.72B
| $15.9M | 1.06% | +197,500 | New | +$15.9M |
|
22
AMN Healthcare
AMN
$796M
| $15.4M | 1.03% | +159,101 | New | +$15.4M |
|
23
Omnicell
OMCL
$1.5B
| $14.9M | 0.99% | +98,366 | New | +$14.9M |
|
24
McKesson
MCK
$85.4B
| $14.4M | 0.96% | 75,000 -47,983 | -39% | -$9.2M |
|
|
TARO
25
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $12.5M | 0.84% | 174,249 +9,871 | +6% | +$710K |
|